Amdocs Limited (DOX) Expected to Announce Earnings of $0.98 Per Share

Share on StockTwits

Equities analysts forecast that Amdocs Limited (NASDAQ:DOX) will announce earnings per share (EPS) of $0.98 for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for Amdocs’ earnings, with estimates ranging from $0.98 to $0.99. Amdocs reported earnings of $0.94 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 4.3%. The firm is scheduled to announce its next earnings report after the market closes on Thursday, November 8th.

According to Zacks, analysts expect that Amdocs will report full year earnings of $4.03 per share for the current year, with EPS estimates ranging from $4.01 to $4.03. For the next year, analysts forecast that the firm will report earnings of $4.31 per share, with EPS estimates ranging from $4.25 to $4.37. Zacks’ earnings per share averages are a mean average based on a survey of analysts that cover Amdocs.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, July 31st. The technology company reported $0.97 EPS for the quarter, hitting analysts’ consensus estimates of $0.97. Amdocs had a net margin of 10.56% and a return on equity of 15.00%. The business had revenue of $1 billion during the quarter, compared to analysts’ expectations of $1.01 billion.

A number of equities analysts have commented on DOX shares. Zacks Investment Research cut shares of Amdocs from a “buy” rating to a “hold” rating in a research note on Wednesday, July 11th. BidaskClub lowered shares of Amdocs from a “hold” rating to a “sell” rating in a report on Friday, July 27th. Barclays set a $73.00 target price on shares of Amdocs and gave the stock a “hold” rating in a report on Wednesday, August 1st. Citigroup decreased their price objective on shares of Amdocs from $79.00 to $77.00 and set a “buy” rating for the company in a report on Thursday, August 2nd. Finally, Robert W. Baird reiterated a “hold” rating and set a $72.00 price objective on shares of Amdocs in a report on Thursday, August 2nd. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average price target of $72.60.

Shares of NASDAQ:DOX traded up $0.13 on Friday, reaching $63.43. The company’s stock had a trading volume of 418,500 shares, compared to its average volume of 689,950. Amdocs has a 52-week low of $60.50 and a 52-week high of $71.72. The stock has a market capitalization of $9.06 billion, a P/E ratio of 17.87, a PEG ratio of 1.84 and a beta of 0.52.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 19th. Investors of record on Friday, September 28th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Thursday, September 27th. This represents a $1.00 dividend on an annualized basis and a yield of 1.58%. Amdocs’s payout ratio is 28.17%.

A number of institutional investors and hedge funds have recently made changes to their positions in DOX. Standard Life Aberdeen plc lifted its holdings in Amdocs by 17.3% during the 2nd quarter. Standard Life Aberdeen plc now owns 2,894,247 shares of the technology company’s stock valued at $191,600,000 after buying an additional 427,752 shares in the last quarter. Cooke & Bieler LP increased its position in Amdocs by 31.9% during the 2nd quarter. Cooke & Bieler LP now owns 1,206,876 shares of the technology company’s stock valued at $79,883,000 after purchasing an additional 292,143 shares during the period. Marshall Wace LLP purchased a new position in Amdocs during the 2nd quarter valued at about $17,597,000. Eagle Asset Management Inc. increased its position in Amdocs by 620.8% during the 2nd quarter. Eagle Asset Management Inc. now owns 269,165 shares of the technology company’s stock valued at $17,816,000 after purchasing an additional 231,822 shares during the period. Finally, Glenmede Trust Co. NA increased its position in Amdocs by 31.1% during the 2nd quarter. Glenmede Trust Co. NA now owns 675,839 shares of the technology company’s stock valued at $44,734,000 after purchasing an additional 160,494 shares during the period. Institutional investors own 90.71% of the company’s stock.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services solutions to the communications, entertainment, pay TV, and media industry service providers worldwide. The company offers customer experience and monetization solutions that allow its customers to contextual and personalize interactions.

See Also: Asset Allocation

Get a free copy of the Zacks research report on Amdocs (DOX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Flexion Therapeutics Inc  is Clearline Capital LP’s 7th Largest Position
Flexion Therapeutics Inc is Clearline Capital LP’s 7th Largest Position
Bell Rock Capital LLC Purchases New Position in Carnival Corp
Bell Rock Capital LLC Purchases New Position in Carnival Corp
Hugo Boss  Given a €61.90 Price Target by Goldman Sachs Group Analysts
Hugo Boss Given a €61.90 Price Target by Goldman Sachs Group Analysts
Mesa Air Group  Given “Buy” Rating at Cowen
Mesa Air Group Given “Buy” Rating at Cowen
LePen Tops 24-Hour Trading Volume of $1.00
LePen Tops 24-Hour Trading Volume of $1.00
Rhenium Price Reaches $0.0007
Rhenium Price Reaches $0.0007


© 2006-2018 Ticker Report